⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Innovacyn, Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Innovacyn, Inc.
↗Rialto, USA
Innovacyn, Inc. is a family-owned, California-based company founded in 2009 that specializes in the development and manufacturing of advanced hypochlorous acid (HOCl) technology. The company provides a range of non-toxic, antibiotic-free wound care, skin management, and infection control products for both human and animal health markets.
Operating out of an FDA-registered, ISO 13485-certified facility in Rialto, California, Innovacyn is known for its flagship brands, Vetericyn (animal health) and Puracyn Plus (human wound care). The company focuses on evidence-based medical devices that support wound bed preparation, debridement, and healing, with a significant global distribution footprint spanning over 27 countries.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1-50
Founded:2009
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Hypochlorous Acid (HOCl)
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Petco (Retail distribution), The Stevens Company (Canadian distributor)
COMPETITION
Position:Niche Player
Competitors:Sonoma Pharmaceuticals, Zoetis, B. Braun Melsungen, Neogen Corporation
LEADERSHIP
Key Executives:
Bob Burlingame - Founder
LINKS
Website:innovacyn.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Innovacyn, Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.